Viewing data from:

DIVALPROEX SODIUM

ANDA

DIVALPROEX SODIUM | A078182 | UPSHER SMITH LABORATORIES LLC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: DEPAKOTE(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 7 NDCs

Highest NADAC/Unit

$0.1605

per ea

Lowest NADAC/Unit

$0.0561

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00832712415DIVALPROEX SOD DR 500 MG TAB	$0.1605	EA	Generic	—	2026-08-19
00832712401DIVALPROEX SOD DR 500 MG TAB	$0.1605	EA	Generic	—	2026-08-19
00832712411DIVALPROEX SOD DR 500 MG TAB	$0.1605	EA	Generic	—	2026-08-19
00832712315DIVALPROEX SOD DR 250 MG TAB	$0.0851	EA	Generic	—	2026-08-19
00832712301DIVALPROEX SOD DR 250 MG TAB	$0.0851	EA	Generic	—	2026-08-19
00832712311DIVALPROEX SOD DR 250 MG TAB	$0.0851	EA	Generic	—	2026-08-19
00832712211DIVALPROEX SOD DR 125 MG TAB	$0.0561	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 6 NDCs (6 FSS)

Lowest Price

$6.57

Highest Price

$119.08

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
00832-7122-11DIVALPROEX SODIUM 125MG DR	$6.57	FSS	Upsher-Smith Laboratories, LLC	04/30/2026
00832-7122-15DIVALPROEX SODIUM 125MG DR	$32.86	FSS	Upsher-Smith Laboratories, LLC	04/30/2026
00832-7123-11DIVALPROEX SODIUM 250MG DR	$10.81	FSS	Upsher-Smith Laboratories, LLC	04/30/2026
00832-7123-15DIVALPROEX SODIUM 250MG DR	$64.57	FSS	Upsher-Smith Laboratories, LLC	04/30/2026
00832-7124-11DIVALPROEX SODIUM 500MG DR	$21.66	FSS	Upsher-Smith Laboratories, LLC	04/30/2026
00832-7124-15DIVALPROEX SODIUM 500MG DR	$119.08	FSS	Upsher-Smith Laboratories, LLC	04/30/2026

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain15 active DMFs5 inactive

14 active API suppliers hold Drug Master Files for this ingredient.

PCASDIVALPROEX SODIUM

DMF 146461999

KATWIJK CHEMIE BVDIVALPROEX SODIUM

DMF 163122002

WOCKHARDT LTDDIVALPROEX SODIUM

DMF 174692004

SCI PHARMTECH INCDIVALPROEX SODIUM

DMF 182852005

SUVEN LIFE SCIENCES LTDDIVALPROEX SODIUM

DMF 192662006

DR REDDYS LABORATORIES LTDDIVALPROEX SODIUM USP

DMF 198712006

SUN PHARMACEUTICAL INDUSTRIES LTDDIVALPROEX SODIUM USP

DMF 198842006

ANJAN DRUG PRIVATE LTDDIVALPROEX SODIUM USP

DMF 200362006

ORBION PHARMACEUTICALS PRIVATE LTDDIVALPROEX SODIUM

DMF 202062007

HARMAN FINOCHEM LTDDIVALPROEX SODIUM USP

DMF 215322008

RAKS PHARMA PVT LTDDIVALPROEX SODIUM USP

DMF 239152010

APITORIA PHARMA PRIVATE LTDDIVALPROEX SODIUM USP

DMF 290972015

HETERO DRUGS LTDDIVALPROEX SODIUM

DMF 314372018

MAITHRI DRUGS PRIVATE LTDDIVALPROEX SODIUM USP

DMF 344402019

SUN PHARMACEUTICAL INDUSTRIES LTDDIVALPROEX SODIUM USP (PROCESS II)

DMF 389112023

SELOC FRNCEInactiveDIVALPROEX SODIUM

DMF 75531988

CILAG AGInactiveDIVALPROEX SODIUM

DMF 162242002

PROCOS SPAInactiveDIVALPROEX SODIUM

DMF 173492004

CHENG FONG CHEMICAL CO LTDInactiveDIVALPROEX SODIUM

DMF 180642005

GENESEN LABS LTDInactiveDIVALPROEX SODIUM

DMF 213412007

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Aug 5, 2008	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (3)

Sort:

#001 — EQ 125MG VALPROIC ACID

0 patents0 exclusivities▴

TABLET, DELAYED RELEASE;ORAL | Approved: Jul 29, 2008

No patent or exclusivity listings for this strength.

#002 — EQ 250MG VALPROIC ACID

0 patents0 exclusivities▾

TABLET, DELAYED RELEASE;ORAL | Approved: Jul 29, 2008

#003 — EQ 500MG VALPROIC ACID

0 patents0 exclusivities▾

TABLET, DELAYED RELEASE;ORAL | Approved: Jul 29, 2008